ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1947-2A>G

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV003330346 SCV004037424 pathogenic Glanzmann thrombasthenia 2023-08-15 reviewed by expert panel curation The NM_000419.5(ITGA2B):c.1947-2A>G splice variant is predicted to result in skipping of exon 20 causing a shift in the reading frame and a premature stop codon in exon 21 leading to nonsense mediated decay in a disease that is loss of function (PVS1). The variant is absent from gnomAD (PM2_supporting). At least one patient, presumed homozygous, with this variant displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia, in addition to αIIbβ3 surface expression of 9-11% compared to WT (PMID:9663713, PP4_moderate). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PM2_Supporting, PP4_moderate, PVS1 (PD VCEP specifications version 2.1).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.